Red Herring

THE BUSINESS OF TECHNOLOGY

  • Startups
  • Mobile
  • Enterprise
  • Consumer
  • Social
  • Events

Israeli Startup Syqe Proves Microdosing Cannabis Relieves Pain Without Side Effects

July 1, 2020

Research conducted by Israeli startup Syqe Medical shows that extremely low doses of the psychoactive constituent THC relieve pain without side effects common to cannabis.

The clinical trial’s results were released today. They show how so-called “microdosing” works with cannabis – whose effectivity as an inhaled pain reliever without side effects has to date been largely anecdotal. The trial’s median time to pain relief was 120 minutes. Harms such as drowsiness, vomiting, nausea or confusion were absent at 30, 60 and 120 minutes after ingestion.

The 85-subject trial could pave the way to a standardized therapeutic window for cannabis inhalation. That would be good news for Syqe, whose selective-dose inhaler allows for personalization of cannabis treatments. The firm’s CEO Perry Davidson told Red Herring he believes “authorities will appreciate that a scientific dosing range for cannabis inhalation is emerging.

“A critical milestone for mainstreaming the various cannabis industries is to define what is a sub-therapeutic, therapeutic, recreational and lastly hazardous dose,” added Davidson, who founded Syqe in 2011, and has raised $70 million in venture capital to date. “This can be seen in industries such as alcohol, where safety and use guidelines were established via a ‘standard drink’ unit, enabling users to control their consumption.

“This foundational element of a ‘standard unit’ is completely lacking in the most popular way cannabis is consumed today – inhalation,” says Davidson.

“We can conclude from the study results that low doses of cannabis may provide desirable effects while avoiding cognitive debilitations, significantly contributing to daily functioning, quality of life, and safety of the patient,” adds professor Elon Eisenberg, of the Technion-Israel Institute of Technology.

As cannabis’ therapeutic benefits have been backed by hard science, and nations have legalized its use, the industry around the drug has skyrocketed in recent years. According to a Fortune Business Insights report, the global cannabis market will be worth just under $100bn by 2026, growing at a shade under 33% CAGR.

  • 
  • 
  • 
  • 

Filed Under: Uncategorized

Related Articles

  • SparkBeyond Proves AI’s Place in Post-Pandemic World
  • Thailand Urges Fake news-busting Centers Across SE Asia
  • Apple to Boost 5G with $1 Billion Intel Buy—But is it Real?

Widget Spacer

Top 100

The Red Herring Top 100 awards highlights the most exciting startups from Asia, Europe and the Americas.

Learn More

Upcoming Events

  • Top 100 Asia

  • Top 100 North America

  • Top 100 Europe

Widget Spacer

Guest Column

What is a Learning Management System?

Rouben David, of CourseForMe.com, outlines the features and benefits of

Widget Spacer

Subscribe

Subscribe now to get event news and updates delivered right to your inbox:

Widget Spacer

#DigitalHerring Tweet

My Tweets
  • About
  • Press & Media
  • Contact Us
Red Herring LinkedInRed Herring Facebook

Copyright © · Red Herring, Inc.

Copyright © 2025 · Red Herring Theme on Genesis Framework · WordPress · Log in